Sava Infond d.o.o.

Position in BSX — Boston Scientific Corp

CIK 2055882 MARIBOR, 2A

Position in BSX

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$3,714,012

+$883,360 QoQ

Shares Held

87,020

+92.9% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#455

of 1,464 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sava Infond d.o.o. holds $8,011,225 across 6 Medical Devices names. BSX ranks #1 (46.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp This page	87,020	$3,714,012
2	ABT	Abbott Laboratories	23,550	$2,136,927
3	SYK	Stryker Corp	2,150	$676,906
4	MDT	Medtronic plc	8,350	$653,220
5	DXCM	Dexcom Inc	7,155	$481,889
6	EW	Edwards Lifesciences Corp	3,850	$348,271

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,714,012	87,020	+92.9%	Shares	Defined	2026-07-16
2026-03-31	$2,830,652	45,110	-13.2%	Shares	Defined	2026-05-11
2025-12-31	$4,957,246	51,990	-1.8%	Shares	Defined	2026-01-29
2025-09-30	$5,166,579	52,920	-1.8%	Shares	Sole	2025-11-10
2025-06-30	$5,786,176	53,870	+13.9%	Shares	Sole	2025-07-22
2025-03-31	$4,772,632	47,310	-4.1%	Shares	Sole	2025-04-23
2024-12-31	$4,404,369	49,310	—	Shares	Sole	2025-02-12
No filing history on record for this holder in this stock.